Polyamine metabolism and cancer: treatments, challenges and opportunities

Robert A. Casero, Tracy Murray Stewart, Anthony E. Pegg

Research output: Contribution to journalReview articlepeer-review

110 Scopus citations

Abstract

Advances in our understanding of the metabolism and molecular functions of polyamines and their alterations in cancer have led to resurgence in the interest of targeting polyamine metabolism as an anticancer strategy. Increasing knowledge of the interplay between polyamine metabolism and other cancer-driving pathways, including the PTEN–PI3K–mTOR complex 1 (mTORC1), WNT signalling and RAS pathways, suggests potential combination therapies that will have considerable clinical promise. Additionally, an expanding number of promising clinical trials with agents targeting polyamines for both therapy and prevention are ongoing. New insights into molecular mechanisms linking dysregulated polyamine catabolism and carcinogenesis suggest additional strategies that can be used for cancer prevention in at-risk individuals. In addition, polyamine blocking therapy, a strategy that combines the inhibition of polyamine biosynthesis with the simultaneous blockade of polyamine transport, can be more effective than therapies based on polyamine depletion alone and may involve an antitumour immune response. These findings open up new avenues of research into exploiting aberrant polyamine metabolism for anticancer therapy.

Original languageEnglish (US)
Pages (from-to)681-695
Number of pages15
JournalNature Reviews Cancer
Volume18
Issue number11
DOIs
StatePublished - Nov 1 2018

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Polyamine metabolism and cancer: treatments, challenges and opportunities'. Together they form a unique fingerprint.

Cite this